- A 'Wisdom Of Experts' Portfolio
- Halozyme Therapeutics - Buy The Drug Delivery Platform And Get A Cancer Drug For Free
- Flamel Technologies: A Turnaround Story With Lots Of Upside
- Gilead Sciences Gets Ambushed By The Patent Troll, AbbVie
- Gilead Sciences: Clear The Dockets And Settle With Merck Already
This user currently has no profile.
A veteran of the pharma industry. Specializing in the analysis of small pharma companies with a focus on the pipeline and opportunities for licensing or major deals with large pharma. Financial analysis including burn rate, venture capital funding, and cash flow.
- Description: Occasional Investor.
- Interests: Bonds, Dividend stock ideas & income, ETFs, Forex, Mutual funds, Options, REITs, Retirement savings, Stocks - long, Stocks - short, Tech stocks
Currently, you have no company profile. Click edit to add a company profile.
Currently, you have no blog details. Click edit to add blog details.
Currently, you have no book details. Click edit to add book details.
LATEST STOCKTALK more »
A "Wisdom Of Experts" Portfolio http://seekingalpha.com/a/1n7w7 Dec 17, 2014
Latest Comments more »
- SC,Thanks for your series o... on Higher Dividends With Less Risk (Part 3): Globa...
- Thanks David for your artic... on Why You Should Hold Foreign Stocks Now
- I am not sure comparing mar... on Recro Pharma: An Overlooked Opportunity With Di...
- Thanks for your excellent a... on Eagle Pharmaceuitcals: The Next Best Generics T...
- Merck and Pfizer are a litt... on Merck's Diabetes Pipeline Candidates Are Sure B...
Latest comments on Small Pharma Analyst's Articles
- Hardog on A 'Wisdom Of Experts' Portfolio
- CSYJ on Gilead Sciences Gets Ambushed By The Patent Tro...
- kahnrb on Gilead Sciences Gets Ambushed By The Patent Tro...
- liegh aulper on Flamel Technologies: A Turnaround Story With Lo...
- Small Pharma Analyst on Halozyme Therapeutics - Buy The Drug Delivery P...
LATEST ARTICLES & INSTAPOSTS more »